Laird Norton Wetherby Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.84M | Buy |
38,053
+2,166
| +6% | +$328K | 0.24% | 61 |
|
|
2025
Q2 | $5.02M | Buy |
+35,887
| New | +$5.03M | 0.22% | 72 |
|
|
2024
Q4 | $4.56M | Sell |
34,789
-3,746
| -10% | -$524K | 0.22% | 74 |
|
|
2024
Q3 | $6M | Buy |
38,535
+917
| +2% | +$148K | 0.27% | 59 |
|
|
2024
Q2 | $5.87M | Buy |
37,618
+1,129
| +3% | +$170K | 0.28% | 59 |
|
|
2024
Q1 | $4.94M | Buy |
36,489
+758
| +2% | +$100K | 0.24% | 72 |
|
|
2023
Q4 | $4.81M | Buy |
35,731
+18
| +0.1% | +$2.34K | 0.25% | 68 |
|
|
2023
Q3 | $4.84M | Sell |
35,713
-730
| -2% | -$99.7K | 0.27% | 65 |
|
|
2023
Q2 | $5.22M | Buy |
36,443
+1,759
| +5% | +$259K | 0.28% | 60 |
|
|
2023
Q1 | $4.81M | Buy |
34,684
+398
| +1% | +$53.5K | 0.28% | 63 |
|
|
2022
Q4 | $4.65M | Buy |
34,286
+1,821
| +6% | +$228K | 0.3% | 60 |
|
|
2022
Q3 | $3.56M | Sell |
32,465
-229
| -0.7% | -$29.1K | 0.25% | 69 |
|
|
2022
Q2 | $4.32M | Buy |
32,694
+2,971
| +10% | +$390K | 0.3% | 55 |
|
|
2022
Q1 | $3.94M | Buy |
29,723
+1,469
| +5% | +$176K | 0.23% | 84 |
|
|
2021
Q4 | $3.29M | Sell |
28,254
-61
| -0.2% | -$7.18K | 0.19% | 100 |
|
|
2021
Q3 | $3.4M | Buy |
28,315
+1,388
| +5% | +$162K | 0.21% | 87 |
|
|
2021
Q2 | $3.23M | Buy |
26,927
+507
| +2% | +$55.6K | 0.2% | 95 |
|
|
2021
Q1 | $2.63M | Sell |
26,420
-821
| -3% | -$82.5K | 0.2% | 95 |
|
|
2020
Q4 | $2.72M | Sell |
27,241
-447
| -2% | -$47.3K | 0.19% | 102 |
|
|
2020
Q3 | $3.04M | Sell |
27,688
-194
| -0.7% | -$21.6K | 0.27% | 75 |
|
|
2020
Q2 | $2.95M | Buy |
27,882
+842
| +3% | +$87K | 0.28% | 72 |
|
|
2020
Q1 | $2.42M | Buy |
27,040
+2,673
| +11% | +$252K | 0.27% | 82 |
|
|
2019
Q4 | $2.43M | Sell |
24,367
-390
| -2% | -$36.7K | 0.24% | 92 |
|
|
2019
Q3 | $2.21M | Buy |
24,757
+1,539
| +7% | +$133K | 0.23% | 100 |
|
|
2019
Q2 | $1.92M | Buy |
23,218
+314
| +1% | +$24.6K | 0.21% | 108 |
|
|
2019
Q1 | $1.85M | Buy |
22,904
+634
| +3% | +$50K | 0.23% | 97 |
|
|
2018
Q4 | $1.69M | Buy |
22,270
+1,061
| +5% | +$82.9K | 0.24% | 93 |
|
|
2018
Q3 | $1.68M | Buy |
21,209
+4
| +0% | +$303 | 0.21% | 105 |
|
|
2018
Q2 | $1.49M | Buy |
21,205
+1,287
| +6% | +$92.6K | 0.2% | 109 |
|
|
2018
Q1 | $1.39M | Buy |
19,918
+1,013
| +5% | +$70.2K | 0.19% | 112 |
|
|
2017
Q4 | $1.31M | Buy |
18,905
+967
| +5% | +$65.2K | 0.18% | 122 |
|
|
2017
Q3 | $1.22M | Buy |
17,938
+351
| +2% | +$22.2K | 0.18% | 124 |
|
|
2017
Q2 | $1.2M | Buy |
17,587
+1,739
| +11% | +$114K | 0.2% | 113 |
|
|
2017
Q1 | $987K | Buy |
15,848
+4,595
| +41% | +$267K | 0.18% | 131 |
|
|
2016
Q4 | $615K | Sell |
11,253
-4,951
| -31% | -$281K | 0.12% | 220 |
|
|
2016
Q3 | $1.06M | Buy |
16,204
+1,808
| +13% | +$118K | 0.22% | 106 |
|
|
2016
Q2 | $869K | Buy |
14,396
+2,520
| +21% | +$146K | 0.19% | 118 |
|
|
2016
Q1 | $669K | Sell |
11,876
-1,320
| -10% | -$79.3K | 0.16% | 146 |
|
|
2015
Q4 | $896K | Buy |
13,196
+846
| +7% | +$55.5K | 0.21% | 104 |
|
|
2015
Q3 | $786K | Buy |
12,350
+1,529
| +14% | +$101K | 0.2% | 106 |
|
|
2015
Q2 | $689K | Buy |
10,821
+638
| +6% | +$43.7K | 0.17% | 140 |
|
|
2015
Q1 | $697K | Sell |
10,183
-770
| -7% | -$53.5K | 0.17% | 133 |
|
|
2014
Q4 | $771K | Buy |
10,953
+1,136
| +12% | +$81.3K | 0.19% | 111 |
|
|
2014
Q3 | $701K | Sell |
9,817
-100
| -1% | -$7.32K | 0.2% | 124 |
|
|
2014
Q2 | $737K | Buy |
9,917
+784
| +9% | +$56.7K | 0.21% | 115 |
|
|
2014
Q1 | $593K | Buy |
9,133
+756
| +9% | +$48.8K | 0.17% | 148 |
|
|
2013
Q4 | $497K | Sell |
8,377
-404
| -5% | -$21.9K | 0.14% | 178 |
|
|
2013
Q3 | $456K | Buy |
8,781
+576
| +7% | +$28.9K | 0.14% | 180 |
|
|
2013
Q2 | $388K | Buy |
+8,205
| New | +$418K | 0.14% | 179 |
|
Other funds holding AZN
